By phone
Alzheimer's Disease Research
Alzheimer’s disease is the most common cause of dementia and accounts for approximately 60-80% of cases. At present, more than 5.8 million Americans are living with AD, and it is now the 6th leading cause of death across the United States, accounting for 1 in 3 deaths among our senior communities, killing more than breast cancer and prostate cancer combined.
A large challenge with Alzheimer’s disease is that there is no cure yet. Current treatments only help with symptoms, not the disease itself. Another issue is diagnosing AD early—before symptoms show and brain damage begins. That is why researchers are working to find better ways to treat, delay, and prevent AD. Some new treatments in late-stage trials look very promising and may be available soon.
At Corewell Health, our Alzheimer’s disease research aims to match the right treatment to the right patient at the right time. We use different research methods to quickly move discoveries from the lab to the clinic, helping improve care for people with AD.
Areas of research
- Early Diagnosis of AD
- Radiation Therapy for AD Treatment
- Clinical Trials
- Alzheimer's Disease pathogenesis (Sharoar Lab)
Contact
Stewart Graham, PhD
Director of Metabolomics Research, John and Marilyn Bishop Foundation Endowed Chair, Director of Alzheimer’s Disease Research, Associate Professor
